古病毒DNA片段调控钙结合蛋白维持胚胎干细胞功能,癌症借此劫持抗衰通路
Ancient viral DNA helps embryonic stem cells grow—and cancer hijacks the same switch
《Science Advances》发表研究称,人类基因组中约1300万年前整合的HERVH序列驱动钙结合蛋白表达,对胚胎干细胞生长和囊胚形成至关重要;该通路在部分肺癌细胞中被重新利用,阻断癌细胞特异的钙结合蛋白形式或成为潜在的抗癌策略。
Three years ago, George Kassiotis and his team made an unexpected discovery: A specific way of producing a protein called calbindin was found to help cancer cells survive by preventing them from aging. This left Kassiotis, who runs the Crick's Retroviral Immunology Laboratory, confused. Why would a mechanism that boosts cancer growth exist in the first place?
In high amounts, calcium can become toxic. Calbindin removes calcium from the cell, and it's normally found in the brain and the kidney, where calcium levels need to be tightly controlled. But Kassiotis' team found that a certain form of calbindin was present in lung cancer cells, switched on by a remnant of viral DNA now embedded in our genome.
"This remnant is called a 'human endogenous retrovirus' or 'HERV,' a holdover from a virus inserting its genetic material into our genome during an infection," explains Kassiotis. "No longer infectious, these stretches of DNA are generally only retained over evolution if our cells have found another use for them. We thought this must be the case for the type of HERV (called HERVH) that switches on calbindin."
Embryonic efficiency
The HERV-calbindin switch had already been seen in cells that make up the early embryo, suggesting it might play a role in this critical period of development.
Judith Pape, then a postdoctoral researcher in Kassiotis' team, teamed up with Kathy Niakan's team, which pioneered genetic editing in human embryos, previously at the Crick and now at the University of Cambridge. Their expertise allowed the researchers to investigate the impact of removing calbindin or the HERVH driving it specifically in human embryonic stem cells. Their findings are now published in the journal Science Advances.
"We managed to genetically edit the cells to remove the ancient HERVH switch so they couldn't produce calbindin. The cells were unhealthy, either failing to grow or becoming fixed as a certain type of cell prematurely," said Pape. "Expertise from our colleagues in the Crick's Stem Cells and Organoids team helped us to keep these unhealthy cells alive long enough to study them further, which was no mean feat."
Pape and Kassiotis next worked with the Cell and Tissue Mechanobiology lab at the Crick to demonstrate an essential role for HERVH-driven calbindin in blastoids, models that mimic an embryonic stage called the blastocyst. "Blastoids without calbindin weren't able to form properly," says Pape. "This suggests that HERVH-calbindin might help the blastocyst's ability to develop and then implant in the uterus."
A fortuitous development from the Quantitative Stem Cell Biology lab at the Crick gave Pape another avenue to explore: the role of HERV-calbindin in the structures that support the embryo.
"Researchers in this lab, who work on how embryonic stem cells become different tissues of the body, had just developed 'post-gastrulation amnioids,' models that mimic the developing amniotic sac, which supports and cushions the embryo," she says. "So, we genetically removed HERVH-calbindin from amnioids, and those without it couldn't develop properly. Some failed to form a sac-like structure entirely."
An evolutionary echo
By comparing primate genomes, the team confirmed that this particular HERVH was integrated after the split of great apes, including humans, from orangutans, approximately 13 million years ago. Calbindin expression in the preimplantation embryo occurred at exactly the same time—unlikely to be a coincidence.
"I see it as making a trade: a chance viral infection gave us a genetic instruction that was more helpful than an old one. We quickly, in evolutionary terms, swapped them out, and the HERVH-calbindin switch became firmly embedded in our blueprint," says Kassiotis.
The trade-off for this evolutionary advantage is that, in a very small proportion of people, cancer cells can make use of the same pathway that kept early embryos healthy. Kassiotis adds, "Removing calcium stops cancer cells aging and allows them to become different types, normal features of embryonic development that have been hijacked."
Future steps: From biomarkers to treatments
The researchers are excited that their results could hold promise for a number of different fields. "In the future, researchers could test if the presence of HERVH-calbindin can act as a biomarker for embryo health in fertility treatments, as embryos with it are more likely to form efficiently," says Pape. "It would also be interesting to explore the role of HERVH-calbindin during and after implantation into the uterus."
In terms of cancer treatment, Kassiotis is clear that it's early days, but because this form of calbindin is different from calbindin in the kidney and brain, it might hold potential as an anticancer target. "It may be possible to block the form of calbindin only found in tumors, stopping cancer from hijacking this antiaging pathway," he reasons. "This allows the primary form of calbindin to continue its critical role of buffering calcium toxicity."
Publication details
Judith Pape et al, Endogenous retrovirus control of calbindin is essential for human early embryogenesis, Science Advances (2026). DOI: 10.1126/sciadv.aee4523
Journal information: Science Advances
Who's behind this story?
Lisa Lock
BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Ancient viral DNA helps embryonic stem cells grow—and cancer hijacks the same switch (2026, October 8) retrieved 8 October 2026 from https://medicalxpress.com/news/2026-10-ancient-viral-dna-embryonic-stem.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com